Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

589 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early antiviral CD4+ and CD8+ T cells are associated with upper airway clearance of SARS-CoV-2.
Ramirez SI, Lopez PG, Faraji F, Parikh UM, Heaps A, Ritz J, Moser C, Eron JJ, Wohl D, Currier J, Daar ES, Greninger A, Klekotka P, Grifoni A, Weiskopf D, Sette A, Peters B, Hughes MD, Chew KW, Smith DM, Crotty S; Accelerating COVID-19 Therapeutic Interventions and Vaccines-2 (ACTIV-2)/A5401 Study Team. Ramirez SI, et al. Among authors: eron jj. JCI Insight. 2024 Dec 20;9(24):e186078. doi: 10.1172/jci.insight.186078. JCI Insight. 2024. PMID: 39704169 Free PMC article.
Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel.
Gandhi RT, Landovitz RJ, Sax PE, Smith DM, Springer SA, Günthard HF, Thompson MA, Bedimo RJ, Benson CA, Buchbinder SP, Crabtree-Ramirez BE, Del Rio C, Eaton EF, Eron JJ Jr, Hoy JF, Lehmann C, Molina JM, Jacobsen DM, Saag MS. Gandhi RT, et al. Among authors: eron jj jr. JAMA. 2024 Dec 1. doi: 10.1001/jama.2024.24543. Online ahead of print. JAMA. 2024. PMID: 39616604
Rapid viral suppression using integrase inhibitors during acute HIV-1 infection.
McKellar MS, Keys JR, Filiatreau LM, McGee KS, Kuruc JD, Ferrari G, Margolis DM, Eron JJ, Hicks CB, Gay CL. McKellar MS, et al. Among authors: eron jj. J Antimicrob Chemother. 2024 Nov 6:dkae391. doi: 10.1093/jac/dkae391. Online ahead of print. J Antimicrob Chemother. 2024. PMID: 39504491
Mpox in People With Human Immunodeficiency Virus: Predictors of Diagnosis, Outcomes, and Vaccine Effectiveness in a Multisite Cohort.
Montaño M, Shapiro AE, Whitney BM, Bamford L, Burkholder G, Cachay ER, Christopoulos KA, Crane HM, Delaney JAC, Eron JJ, Fredericksen RJ, Hunt PW, Jacobson JM, Keruly JC, Kim HN, Mayer KH, Moore RD, Napravnik S, Pettit A, Saag MS, Yendewa GA, Kitahata MM, Bender Ignacio RA. Montaño M, et al. Among authors: eron jj. Clin Infect Dis. 2024 Oct 8:ciae464. doi: 10.1093/cid/ciae464. Online ahead of print. Clin Infect Dis. 2024. PMID: 39377755
Characterizing long-acting injectable antiretroviral therapy eligibility and initiation at a safety net academic medical center in the southeastern United States.
Rutstein SE, Lopez C, Davy-Mendez T, Agarwal H, Huffstetler H, Perhac A, Turner B, Eron JJ, Go V, Farel CE, Li KP, Napravnik S. Rutstein SE, et al. Among authors: eron jj. Int J STD AIDS. 2025 Jan;36(1):47-55. doi: 10.1177/09564624241289998. Epub 2024 Oct 3. Int J STD AIDS. 2025. PMID: 39361721
Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial.
Evering TH, Moser C, Jilg N, Ritz J, Wohl DA, Li JZ, Margolis D, Javan AC, Eron JJ, Currier JS, Daar ES, Smith DM, Hughes MD, Chew KW; ACTIV-2/A5401 Study Team. Evering TH, et al. Among authors: eron jj. EClinicalMedicine. 2024 Aug 16;75:102787. doi: 10.1016/j.eclinm.2024.102787. eCollection 2024 Sep. EClinicalMedicine. 2024. PMID: 39252866 Free PMC article.
Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody Response.
Paul MK, Choudhary MC, Heaps AL, Deo R, Moisi D, Gordon KC, Mellors JW, Moser C, Klekotka P, Landay A, Currier JS, Eron JJ, Chew KW, Smith DM, Sieg SF, Parikh UM, Li JZ; ACTIV-2/A5401 Study Team. Paul MK, et al. Among authors: eron jj. Pathog Immun. 2024 Aug 21;9(2):79-93. doi: 10.20411/pai.v9i2.718. eCollection 2024. Pathog Immun. 2024. PMID: 39247686 Free PMC article.
Comparison Study of the Bio-Plex and Meso Scale Multiplexed SARS-CoV-2 Serology Assays Reveals Evidence of Diminished Host Antibody Responses to SARS-CoV-2 after Monoclonal Antibody Treatment.
Parikh UM, Heaps AL, Moisi D, Gordon KC, Mellors JW, Choudhary MC, Deo R, Moser C, Klekotka P, Landay AL, Currier JS, Eron JJ, Chew KW, Smith DM, Li JZ, Sieg SF; Team ACTIV-2/A5401 Study. Parikh UM, et al. Among authors: eron jj. Pathog Immun. 2024 Aug 15;9(2):58-78. doi: 10.20411/pai.v9i2.715. eCollection 2024. Pathog Immun. 2024. PMID: 39165724 Free PMC article.
589 results